Microtracer dosing in drug development: sensitive analysis for more efficient pipelines

The development of new medicines is a costly and timeconsuming process. As a result, companies are always locking for ways to increase the efficiency of their pipeline. One way to do that is by using microtracer dosing. Microtracing is an innovative technology in which very small quantities of substances are tested in humans at very early stage of development. In microtracing, small quantities, no more than 100 micrograms, are administered. This is less than one hundredth of the expected therapeutic dose, a quantity that does not cause side-effects.